Inactive Instrument

SCAPA GROUP

Equities

SCPA

GB0007281198

Scapa Group plc Reports Revenue Results for the Six Months Ended 30 September 2019

October 09, 2019 at 02:00 am EDT

Scapa Group plc reported revenue results for the six months ended 30 September 2019. On a statutory basis, revenues grew 14.3% (10.4% on a constant currency basis) predominantly driven by Healthcare and the full period effect of the Systagenix technology transfer. Statutory group trading profits reflect the impact of the loss of the ConvaTec contract and are expected to be approximately 17.0% below last year.

Latest news about SCAPA GROUP

Schweitzer Mauduit International : Finalizes Acquisition of Scapa Group	21-04-15	MT
Schweitzer-Mauduit International, Inc. completed the acquisition of Scapa Group plc from a group of sellers.	21-04-14	CI
Scapa : Court Approves Scapa Group Acquisition By Schweitzer-Mauduit International Unit	21-04-13	MT
Scapa : Schweitzer-Mauduit Unit Lifts Scapa Takeover Bid to $571 Million	21-03-08	MT
Schweitzer Mauduit International : Mauduit to Buy UK's Scapa Group in GBP402.9 Million Deal	21-01-27	MT
Scapa : Schweitzer-Mauduit Unit Agrees to Take Over Scapa for $553.7 Million	21-01-27	MT
Schweitzer-Mauduit International, Inc. entered into a Scheme of Arrangement to acquire Scapa Group plc from a group of sellers for approximately £410 million.	21-01-26	CI
Scapa : Earnings Flash (SCPA.L) SCAPA GROUP Reports H1 EPS GBX-0.2	20-11-17	MT
Scapa : Earnings Flash (SCPA.L) SCAPA GROUP Reports H1 Revenue GBP122M	20-11-17	MT
Scapa Group plc Provides Revenue Guidance for the Second Half of Year 2020	20-11-17	CI
Scapa Group plc Reports Earnings Results for the Half Year Ended September 30, 2020	20-11-17	CI
Scapa Group plc Announces Revenue Results for the Six Months Ended 30 September 2020	20-10-13	CI
Certain Ordinary Shares of Scapa Group plc are subject to a Lock-Up Agreement Ending on 12-SEP-2020.	20-09-11	CI
Scapa Group plc Announces Board Changes	20-08-07	CI
Scapa Group plc Announces David Blackwood, Non-Executive Director, Intends to Step Down by the End of the Calendar Year 2020	20-08-07	CI
Scapa Group plc Announces Board Changes	20-06-23	CI
Scapa Group plc Reports Earnings Results for the Full Year Ended March 31, 2020	20-06-23	CI
Scapa Group plc Reports Revenue Results for the Year Ended March 31, 2020; Provides Revenue Guidance for the First Quarter of Fiscal Year 2021	20-05-14	CI
Scapa Group plc Announces Organizational and Board Changes	20-05-04	CI
Scapa Group plc Intends to Suspend the Annual Dividend	20-03-26	CI
Scapa Group plc Announces the Retirement of Pierre Guyot as Non-Executive Director of the Company, Effective 29 February 2020	20-02-28	CI
Scapa Group plc Provides Earnings Guidance for the Year 2020	20-02-12	CI
Scapa Group plc Appoints Tim Miller as Non-Executive Director	20-01-20	CI
Scapa Group plc Reports Earnings Results for the Half Year Ended September 30, 2019	19-11-19	CI
Scapa Group plc Reports Revenue Results for the Six Months Ended 30 September 2019	19-10-09	CI

Chart SCAPA GROUP

Duration

Period

More charts

Company Profile

Scapa Group plc is a United Kingdom-based global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets. The Company has a global footprint, with production sites in Asia, Europe and the United States. The Company conducts the activities through two distinct and separate businesses: Healthcare and Industrial business units. The Company's subsidiary Scapa Healthcare is a outsource partner in the advanced wound care, consumer wellness, medical device fixation and drug delivery markets. Scapa Industrial operates across a diverse range of market segments throughout Europe, North America and Asia, through the two business models of engineered products and commercial products.

Sector

More about the company